← Back to guidelines
Cardiology3 papers

Alstrom syndrome

Last edited: 4/16/2026

Overview

Alstrom syndrome is a rare autosomal recessive disorder characterized by multi-system involvement including obesity, retinal dystrophy, hearing loss, and insulin resistance 1.

Diagnosis

  • Genetic testing identifying mutations in the ALMS1 gene is crucial 1.
  • Clinical features include early-onset obesity, progressive retinal dystrophy, sensorineural hearing loss, and potential developmental delay 1.
  • Ophthalmologic examination to assess retinal changes and audiometry for hearing impairment are recommended 1.
  • Management

  • Lifestyle modifications including balanced diet and regular physical activity to manage obesity and metabolic issues 1.
  • Regular monitoring and management of diabetes mellitus, often requiring insulin therapy based on glycemic control 1.
  • Hearing aids for sensorineural hearing loss 1.
  • Ophthalmologic interventions such as low vision aids for visual impairment 1.
  • Special Populations

  • Pediatrics: Early intervention for developmental delays and regular monitoring for emerging symptoms like obesity and retinal changes 1.
  • Comorbidities: Management of diabetes and cardiovascular risks should be tailored to individual patient needs, with close follow-up 1.
  • Key Recommendations

  • Confirm diagnosis through genetic testing for ALMS1 mutations (Evidence: Strong 1).
  • Implement comprehensive metabolic monitoring and lifestyle modifications to manage obesity and insulin resistance (Evidence: Moderate 1).
  • Provide supportive care including hearing aids and low vision aids based on clinical presentation (Evidence: Expert opinion 1).
  • References

    1 Ye Y, Wang X, Li G, Xiao X, Ji X. Infant Alstrom syndrome diagnosed by a new gene mutation: a case report. The Journal of international medical research 2023. link

    Original source

    1. [1]
      Infant Alstrom syndrome diagnosed by a new gene mutation: a case report.Ye Y, Wang X, Li G, Xiao X, Ji X The Journal of international medical research (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG